Background Image
Previous Page  135 / 156 Next Page
Information
Show Menu
Previous Page 135 / 156 Next Page
Page Background

133

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

115

Griffiths JD, Middle JV, Barron FA, Grant SJ, Popham PA, Royse CF. Transversus abdominis

plane block does not provide additional benefit to multimodal analgesia in gynecological

cancer surgery. Anesth Analg 2010; 111(3): 797-801.

116

Grover VK, Mathew PJ, Yaddanapudi S, Sehgal S. A single dose of preoperative gabapen-

tin for pain reduction and requirement of morphine after total mastectomy and axillary

dissection: randomized placebo-controlled double-blind trial. J Postgrad Med 2009;

55(4): 257-260.

117

Hagen NA, du Souich P, Lapointe B, Ong-Lam M, Dubuc B, Walde D, Love R, Ngoc

AH;Canadian Tetrodotoxin Study Group. Tetrodotoxin for moderate to severe cancer

pain: a randomized, double blind, parallel design multicenter study. J Pain Symptom

Manage 2008; 35(4): 420-429.

118

Hagen NA, Fisher K, Victorino C, Farrar JT. A titration strategy is needed to manage break-

through cancer pain effectively: observations from data pooled from three clinical trials. J

Palliat Med 2007; 10(1): 47-55.

119

Hagen NA, Moulin DE, Brasher PM, Biondo PD, Eliasziw M, Watanabe SM, Stiles CR. A

formal feasibility study of sublingual methadone for breakthrough cancer pain. Palliat

Med 2010; 24(7): 696-706.

120

Hald K, Klow NE, Qvigstad E, Istre O. Laparoscopic occlusion compared with embolization

of uterine vessels: a randomized controlled trial. Obstet Gynecol 2007; 109(1): 20-27.

121

Hanaoka K, Yoshimura T, Tomioka T, Sakata H. [Clinical study of one-day fentanyl patch in

patients with cancer pain--evaluation of the efficacy and safety in relation to treatment

switch from opioid analgesic therapy]. Masui 2011; 60(2): 147-156.

122

Hashiguchi S, Morisaki H, Kotake Y, Takeda J. Effects of morphine and its metabolites on

immune function in advanced cancer patients. J Clin Anesth 2005; 17(8): 575-580.

123

Hashizume T, Tomiyasu S, Yomiya K, Yoshimoto T, Harada A, Matoba M. [Validity of

recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in

prescribing information - multicenter survey of on prescriptions by palliative care specia-

lists in Japan]. Gan To Kagaku Ryoho 2007; 34(6): 897-902.

124

Haslbauer F, Fiegl M. Bisphosphonates as adjuvant therapy in multimodal pain manage-

ment. Memo – Magazine of European Medical Oncology 2009; 2 (3), 161 – 165.

125

Hawley P, Beddard-Huber E, Grose C, McDonald W, Lobb D, Malysh L. Intrathecal infu-

sions for intractable cancer pain: a qualitative study of the impact on a case series of

patients and caregivers. Pain Res Manag 2009; 14(5): 371-379.

126

He BM, Li WS, Li WY. [Effect of previous analgesia of scalp acupuncture on post-operative

epidural morphine analgesia in the patient of intestinal cancer]. Zhongguo Zhen Jiu 2007;

27(5): 369-371.

127

Heiskanen T, Matzke S, Haakana S, Gergov M, Vuori E, Kalso E. Transdermal fentanyl in

cachectic cancer patients. Pain 2009; 144(1-2): 218-222.

128

Heller L, Kowalski AM, Wei C, Butler CE. Prospective, randomized, double-blind trial of

local anesthetic infusion and intravenous narcotic patient-controlled anesthesia pump for

pain management after free TRAM flap breast reconstruction. Plast Reconstr Surg 2008;

122(4): 1010-1018.

Literaturverzeichnis